CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
about
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
description
article publié dans la revue scientifique Scientific Reports
@fr
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Scientific Reports
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@en
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@nl
type
label
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@en
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@nl
prefLabel
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@en
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@nl
P2093
P2860
P1433
P1476
CDKN2A as transcriptomic marke ...... on and therapy decision-making
@en
P2093
Arndt Hartmann
Cleo-Aron Weis
Johannes Breyer
Markus Eckstein
Philipp Erben
Ralph M Wirtz
Robert Stöhr
Simone Bertz
Wolfgang Otto
P2860
P2888
P356
10.1038/S41598-018-32569-X
P407
P577
2018-09-26T00:00:00Z
P6179
1107129431